medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2026, Number 2

<< Back Next >>

Cir Gen 2026; 48 (2)

Blood glucose management in postoperative patients: current evidence and recommendations

Torres-Torres DA, Camacho-Vázquez MO, Vargas-Fraga JM, Avila-Caballero A, González-Soto XN

Language: Spanish
References: 32
Page: 86-95
PDF size: 663.76 Kb.


ABSTRACT

Introduction: postoperative hyperglycemia is a common metabolic disturbance associated with increased risk of complications in surgical patients, including those without previously diagnosed diabetes. The physiological response to surgical stress promotes hormonal changes that elevate glucose levels and may impair immune function, wound healing, and overall recovery. Objective: to review current evidence on postoperative glycemic control and summarize relevant recommendations from recent literature. Material and methods: a literature review was conducted using multiple electronic resources. Clinical trials, systematic reviews, meta-analyses, and guidelines published between 2015 and 2026 in English or Spanish were included. After screening the identified studies, 30 articles were selected for analysis. Results: postoperative hyperglycemia has been consistently associated with higher rates of surgical site infections, cardiovascular complications, sepsis, and prolonged hospitalization. Current recommendations suggest glycemic targets of 140-180 mg/dl for critically ill patients and 100-180 mg/dl for non-critical patients. Insulin remains the preferred therapy in hospitalized patients, particularly using basal–bolus regimens. Frequent glucose monitoring and structured institutional protocols are essential to reduce adverse events, especially hypoglycemia. Conclusions: appropriate postoperative glycemic management is essential to reduce complications and improve surgical outcomes. Standardized protocols and multidisciplinary care play an important role in optimizing glucose control in surgical patients.


REFERENCES

  1. Goodenough CJ, Liang MK, Nguyen MT, et al.Preoperative glycosylated hemoglobin and postoperativeglucose together predict major complications afterabdominal surgery. Journal of the American College ofSurgeons. 2015; 221: 854-861e1. Available in: https://doi.org/10.1016/j.jamcollsurg.2015.07.013

  2. Cheisson G, Jacqueminet S, Cosson E, et al.Perioperative management of adult diabetic patients.Intraoperative period. Anaesth Crit Care PainMed. 2018; 37: S21-S25. Available in: https://doi.org/10.1016/j.accpm.2018.02.018

  3. Galway U, Chahar P, Schmidt MT, et al. Perioperativechallenges in management of diabetic patientsundergoing non-cardiac surgery. World J Diabetes.2021; 12: 1255-1266. Available in: https://doi.org/10.4239/wjd.v12.i8.1255

  4. Mangram AJ, Horan TC, Pearson ML, Silver LC.Guideline for prevention of surgical site infection.Infect Control Hosp Epidemiol. 1999; 20: 250-278;quiz 279-80.

  5. Bellon F, Solŕ I, Gimenez-Perez G, Hernández M, etal. Perioperative glycaemic control for people withdiabetes undergoing surgery. Cochrane Database SystRev. 2023; 8: CD007315. Available in: https://doi.org/10.1002/14651858.CD007315.pub3

  6. Todd LA, Vigersky RA. Evaluating perioperativeglycemic control of non-cardiac surgical patients withdiabetes. Mil Med. 2021; 186: e867-e872. Availablein: https://doi.org/10.1093/milmed/usaa467

  7. Anderson DJ, Podgorny K, Berríos-Torres SI, et al.Strategies to prevent surgical site infections in acutecare hospitals: 2014 update. Infect Control HospEpidemiol. 2014; 35: 605-627. Available in: https://doi.org/10.1086/676022.

  8. Borchardt RA, Tzizik D. Update on surgical siteinfections: the new CDC guidelines. JAAPA. 2018;31: 52-54. Available in: https://doi.org/10.1097/01.JAA.0000531052.82007.42

  9. Calderwood MS, Anderson DJ, Bratzler DW, et al.Strategies to prevent surgical site infections in acutecarehospitals: 2022 Update. Infect Control HospEpidemiol. 2023; 44: 695-720. Available in: https://doi.org/10.1017/ice.2023.67

  10. Finney SJ, Zekveld C, Elia A, Evans TW. Controlde la glucosa y mortalidad en pacientes en estadocrítico. JAMA. 2003; 290: 2041-2047. doi: 10.1001/jama.290.15.2041.

  11. NICE-SUGAR Study Investigators; Finfer S, ChittockDR, et al. Intensive versus conventional glucose controlin critically ill patients. N Engl J Med. 2009; 360: 1283-

  12. 1297.12. Yamada T, Shojima N, Noma H, Yamauchi T, KadowakiT. Glycemic control, mortality, and hypoglycemia incritically ill patients: a systematic review and networkmeta-analysis of randomized controlled trials. IntensiveCare Med. 2017; 43: 1-15. Available in: https://doi.org/10.1007/s00134-016-4523-0.

  13. Yao RQ, Ren C, Wu GS, et al. Is intensive glucosecontrol bad for critically ill patients? A systematicreview and meta-analysis. Int J Biol Sci. 2020; 16:1658-1675. Available in: https://doi.org/10.7150/ijbs.43447

  14. American Diabetes Association Professional PracticeCommittee. 7. Diabetes Technology: Standards ofCare in Diabetes-2025. Diabetes Care. 2025; 48:S146-S166. Available in: https://doi.org/10.2337/dc25-S007

  15. American Diabetes Association Professional PracticeCommittee. 6. Glycemic Goals and Hypoglycemia:Standards of Care in Diabetes-2025. Diabetes Care.2025; 48: S128-S145. Available in: https://doi.org/10.2337/dc25-S006

  16. Duggan EW, Klopman MA, Berry AJ, Umpierrez G.The Emory university perioperative algorithm forthe management of hyperglycemia and diabetes innon-cardiac surgery patients. Curr Diab Rep. 2016;16: 34. Available in: https://doi.org/10.1007/s11892-016-0720-z

  17. Van den Boom W, Schroeder RA, Manning MW, SetjiTL, Fiestan GO, Dunson DB. Effect of A1C and glucoseon postoperative mortality in noncardiac and cardiacsurgeries. Diabetes Care. 2018; 41: 782-788. Availablein: https://doi.org/10.2337/dc17-2232

  18. American Diabetes Association Professional PracticeCommittee. 16. Diabetes Care in the Hospital:Standards of Care in Diabetes-2025. Diabetes Care.2025; 48: S321-S334. Available in: https://doi.org/10.2337/dc25-S016

  19. Jiang J, Li S, Zhao Y, et al. Intensive glucosecontrol during the perioperative period for diabeticpatients undergoing surgery: an updated systematicreview and meta-analysis. J Clin Anesth. 2021; 75:110504. Available in: https://doi.org/10.1016/j.jclinane.2021.110504

  20. Thongsuk Y, Hwang NC. Perioperative glycemicmanagement in cardiac surgery: a narrativereview. J Cardiothorac Vasc Anesth. 2024; 38:248-267. Available in: https://doi.org/10.1053/j.jvca.2023.08.149

  21. Smith NT, Xiong S, Bergquist WJ, Blader LR, TangKK, Cima RR. Improved postoperative blood glucosecontrol through implementation of clinical pharmacistdriven glycemic management model after colorectalsurgery. Am J Surg. 2023; 225: 1050-1055. Availablein: https://doi.org/10.1016/j.amjsurg.2022.12.018

  22. Polderman JAW, Hermanides J, Hulst AH. Update onthe perioperative management of diabetes mellitus.BJA Educ. 2024; 24: 261-269. Available in: https://doi.org/10.1016/j.bjae.2024.04.007

  23. Crowley K, Scanaill PÓ, Hermanides J, Buggy DJ.Current practice in the perioperative management ofpatients with diabetes mellitus: a narrative review. BrJ Anaesth. 2023; 131: 242-252. Available in: https://doi.org/10.1016/j.bja.2023.02.039

  24. Kincaid K, Boitano TKL, Scalise M, Patton S,Leath CA 3rd, Straughn JM Jr, et al. Impact ofsteroid use and glycemic control on postoperativecomplications in diabetic gynecologic oncologypatients undergoing laparotomy. Gynecol OncolRep. 2024; 52: 101344. Available in: https://doi.org/10.1016/j.gore.2024.101344

  25. Wang YY, Hu SF, Ying HM, et al. Postoperative tightglycemic control significantly reduces postoperativeinfection rates in patients undergoing surgery: a metaanalysis.BMC Endocr Disord. 2018; 18: 42. doi:10.1186/s12902-018-0268-9

  26. Fragoso LVC, Araújo MFM, Lobo LFDS, SchreenD, Zanetti ML, Damasceno MMC. Bolus versuscontinuous insulin infusion in immediate postoperativeblood glucose control in liver transplantation:pragmatic clinical trial. Einstein (Sao Paulo). 2022;20: eAO6959. Available in: https://doi.org/10.31744/einstein_journal/2022AO6959

  27. Oliveira RA, Tanner J, Mancero JMP, de Brito PovedaV. Effects of intensive blood glucose control onsurgical site infection for liver transplant recipients: arandomized controlled trial. Transplant Proc. 2023;55: 170-177. Available in: https://doi.org/10.1016/j.transproceed.2022.10.062

  28. Carlier L, De Ponthaud C, Jacqueminet S, Phan F,Gaujoux S, Amouyal C. Perioperative use and accuracyof continuous glucose monitoring: a systematicreview. Diabetes Obes Metab. 2025; 27: 5393-5408.Available in: https://doi.org/10.1111/dom.16583

  29. Putzu A, Grange E, Schorer R, Schiffer E, GarianiK. Continuous peri-operative glucose monitoringin noncardiac surgery: a systematic review. Eur JAnaesthesiol. 2025; 42: 162-171. Available in: https://doi.org/10.1097/EJA.0000000000002095

  30. Cua S, Humeidan M, Beal EW, et al. The effect of anenhanced recovery protocol on colorectal surgerypatients with diabetes. J Surg Res. 2021; 257: 153-160.Available in: https://doi.org/10.1016/j.jss.2020.07.041

  31. Vallejo AE, Colina VYA, Trujillo ZJA, et al. Controlglicémico perioperatorio. Revista Chilena de Anestesia.2021; 50: 731-739. Disponible en: https://doi.org/10.25237/revchilanestv5011081503

  32. Dhatariya KK. Perioperative management of peoplewith diabetes undergoing surgery. Br J Surg. 2025;113: znaf291. Available in: https://doi.org/10.1093/bjs/znaf291




2020     |     www.medigraphic.com